TCRR
Fidelity Investments’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-120,633
| Closed | -$181K | – | 5666 |
|
|
2023
Q1 | $181K | Buy |
120,633
+6,772
| +6% | +$10.2K | ﹤0.01% | 3017 |
|
|
2022
Q4 | $114K | Buy |
113,861
+10,940
| +11% | +$10.9K | ﹤0.01% | 3165 |
|
|
2022
Q3 | $185K | Sell |
102,921
-433
| -0.4% | -$778 | ﹤0.01% | 3069 |
|
|
2022
Q2 | $300K | Sell |
103,354
-344
| -0.3% | -$999 | ﹤0.01% | 3013 |
|
|
2022
Q1 | $286K | Buy |
103,698
+103,423
| +37,608% | +$285K | ﹤0.01% | 3158 |
|
|
2021
Q4 | $1K | Sell |
275
-221,360
| -100% | -$805K | ﹤0.01% | 4243 |
|
|
2021
Q3 | $1.89M | Sell |
221,635
-203,165
| -48% | -$1.73M | ﹤0.01% | 2578 |
|
|
2021
Q2 | $6.97M | Sell |
424,800
-33,900
| -7% | -$556K | ﹤0.01% | 2232 |
|
|
2021
Q1 | $10.1M | Hold |
458,700
| – | – | ﹤0.01% | 2031 |
|
|
2020
Q4 | $14.2M | Buy |
458,700
+66,200
| +17% | +$2.05M | ﹤0.01% | 1847 |
|
|
2020
Q3 | $7.98M | Buy |
+392,500
| New | +$7.98M | ﹤0.01% | 1903 |
|
|
2019
Q4 | – | Sell |
-78
| Closed | -$1K | – | 4387 |
|
|
2019
Q3 | $1K | Buy |
+78
| New | +$1K | ﹤0.01% | 3703 |
|